c-myc, not her-2/neu, can predict the prognosis of breast cancer patients: how novel, how accurate, and how significant?
The predictive and prognostic implication of oncogene amplification in breast cancer has received great attention in the past two decades. her-2/neu and c-myc are two oncogenes that are frequently amplified and overexpressed in breast carcinomas. Despite the extensive data on these oncogenes, their...
Guardat en:
| Publicat a: | Breast Cancer Res |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2003
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC165018/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12817989/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr606 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|